HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 03, March 2017 – Get to Know TCM       » Chinese Scientists in Rice Breakthrough       » Leading Regional Medical Technology Trade Associations Reinforce their Commitment to Evidence-based Healthcare       » New Study Finds Extensive Use of Fluorinated Chemicals in Fast Food Wrap       » What Doesn't Kill You Makes You Stronger       » Life Under Pressure       » Understanding the Genetics of Human Height      
BIOBOARD - AUSTRALIA
Women: Hormone therapy won’t harm your head
Women do not suffer cognitive loss when taking hormone replacement therapy to treat symptoms of menopause, a new study finds.

Researchers tested the treatment for six months in early postmenopausal women between the ages of 49 and 55 who had never used HRT E2D—a combination of hormones estradiol and drospirenone. The examined HRT's effects on memory, language and concentration.

The treatment resulted in significant improvement in menopausal symptoms including hot flushes, night sweats, and sexual function, and it lowered blood pressure and weight in comparison to those who were treated with an identical placebo.

The women underwent cognitive assessment and were asked to perform mental tasks during a brain-imaging (MRI) scan. The researchers found no effect on the cognitive performance of early postmenopausal women.

Professor Susan Davis, director of the Women's Health Research Program in the Monash University School of Public Health and Preventive Medicine, says there had long been debate about the safety of hormone replacement therapies and the potential adverse effects on cognitive function in women.

Davis says memory and mood complaints were frequent in women after menopause due to oestrogen deficiency, including a lack of clarity of thought and memory or word-finding difficulties.

“These findings are reassuring for women,” Davis says.

“We report, for the first time, that drospirenone combined with estradiol has no overall effect on the cognitive performance of postmenopausal women examined over a 26-week period.

“Although hormone replacement therapy is no quick fix to the challenge of menopause, it does show that the E2D treatment can be useful in the overall management of menopause, and without adversely effecting cognitive ability.”

Click here for the complete issue.

NEWS CRUNCH  
news Philip Morris International and British American Tobacco receive award from PETA science group for AOP developments
news 6th Asia-Pacific Breast Cancer Summit to take place in Hong Kong
news MIT Hacking Medicine Robotics in Singapore!
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetics Technology
May:
The Piece of Your Mind - Brain Health/Science
June:
Women & Men's Health
July:
Food Science & Technology
August:
Eye Care/ Eye Health
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy